Richard Brounstein

Richard Brounstein, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in HeartBeam, Inc. and Calypte Biomedical Corp. In total, 19 filings cover trades dated from 28 March 2007 to 10 February 2023.

On the market, this insider has only ever bought: 2 purchases, €41k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants and 14 option exercises.

The latest filing, published on 14 February 2023, reports an option exercise in HeartBeam, Inc. The last purchase on record was published on 23 December 2021, which is 1,782 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.